The Lancet32m
The time for regionalised vaccine manufacturing has arrived
The current approach to global vaccine research and development (R&D), manufacturing, and distribution has greatly expanded routine immunisation, achieving substantial reductions in disease burden ...
Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom As Over 100 Companies Leading The Charge In Research And Development Delveinsight
DelveInsight's NSCLC pipeline report depicts a robust space with 100+ active players working to develop 120+ pipeline therapies for NSCLC treatment. Key NSCLC companies such as Merck Sharp & Dohme LLC ...